Presentation TVT 2021 The Bioventrix Technology and Optimal Patient Candidate Presenter: Jerry D. Estep July 22, 2021
Presentation TVT 2021 The Accucinch Technology and Optimal Patient Candidate Presenter: Ulrich P. Jorde July 22, 2021
News Conference News TVT 2021 Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market Todd Neale July 22, 2021
Presentation TVT 2021 The Physiology of Mechanical (Device-Based) vs Biological (Medical Therapy-Based) Reverse Remodeling Presenter: Michael I. Brener July 22, 2021
Presentation TVT 2021 Transseptal Implantation of HighLife Self-expandable Mitral Valve in a Patient With Severe Secondary Mitral Regurgitation and Heart Failure Presenter: Wojtek Wojakowski July 21, 2021
News Conference News TVT 2021 Timing of Mitral Surgery After Failed TEER Influences Outcomes Todd Neale July 21, 2021
News Daily News Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns Shelley Wood July 20, 2021
Presentation TVT 2021 Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial Presenter: Gennaro Giustino July 20, 2021
News Daily News Hospital Stays for Meth-Related HF Skyrocket, as Do Costs Caitlin E. Cox July 14, 2021
News Daily News Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists Todd Neale July 09, 2021
News Daily News FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes Yael L. Maxwell July 09, 2021
News Daily News Outcomes Worse With Combined Transcatheter Aortic, Mitral Procedures Todd Neale July 07, 2021
News Conference News ESC Heart Failure 2021 Beta-blocker Withdrawal Boosts Peak VO2 in HFpEF Subset: PRESERVE-HR Shelley Wood July 06, 2021
News Daily News Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data Caitlin E. Cox July 06, 2021